
Core Insights - ProAssurance reported revenue of $278.54 million for Q2 2024, a year-over-year decline of 1.3%, with an EPS of $0.23 compared to $0.16 a year ago, indicating a significant EPS surprise of +187.50% against the consensus estimate of $0.08 [1] Financial Performance Metrics - Combined Ratio was reported at 110.9%, better than the average estimate of 112.4% from five analysts [3] - Underwriting Expense Ratio stood at 33.4%, higher than the average estimate of 31.6% from five analysts [4] - Net Loss Ratio was 77.5%, outperforming the average estimate of 80.7% from five analysts [5] - Underwriting Expense Ratio for Workers Compensation was 36.2%, above the average estimate of 34.4% from three analysts [6] - Net Premiums Earned totaled $239.87 million, slightly above the average estimate of $235.03 million from five analysts, reflecting a year-over-year decline of 3.2% [7] - Net Investment Income was reported at $36.56 million, exceeding the average estimate of $34.47 million from five analysts, marking a year-over-year increase of 15.5% [8] - Equity in earnings of unconsolidated subsidiaries was $8.65 million, significantly higher than the average estimate of $2.58 million from five analysts [9] - Other income was reported at $2.12 million, below the average estimate of $3.44 million from five analysts, representing a year-over-year decline of 22.8% [10] - Net Premiums Earned in Specialty Property & Casualty was $184.55 million, slightly above the average estimate of $184.45 million from three analysts, showing a year-over-year increase of 3.2% [10] - Net Premiums Earned in Segregated Portfolio Cell Reinsurance was $13.55 million, below the average estimate of $14.56 million from three analysts, reflecting a significant year-over-year decline of 43.8% [11] - Net Premiums Earned in Workers Compensation was $41.77 million, exceeding the average estimate of $41.04 million from three analysts, with a year-over-year increase of 1.8% [12] - Net Investment Income in Segregated Portfolio Cell Reinsurance was $0.99 million, surpassing the average estimate of $0.71 million from two analysts, indicating a year-over-year increase of 63.4% [13] Stock Performance - ProAssurance shares have returned +2.3% over the past month, contrasting with the Zacks S&P 500 composite's decline of -6.5%, and the stock currently holds a Zacks Rank 3 (Hold) [13]